Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Immune checkpoint inhibitors used in cancer therapy can cause hair loss, and understanding this can help manage the side effect.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

Melanocytes may trigger the immune response in alopecia areata, affecting hair regrowth.

Clonally expanded CD8+ T cells cause alopecia areata.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Cells from the lower part of hair follicles are a promising, less invasive option for immune system therapies.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

The study suggested certain immune cells might cause alopecia areata, but it was retracted.

New therapies aim to improve long-term hair regrowth in alopecia areata by targeting immune responses.

Type I interferons play a key role in the development of various skin diseases.

Telocytes in the scalp may help with skin regeneration and maintenance.

Immunofluorescence tomography is a cost-effective method for creating detailed 3-D images of tissues.

Human hair follicle cells can help regenerate hair and reduce inflammation, aiding in hair loss treatment.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

Gamma delta T cells in the skin help with healing and defense but can also cause autoimmune issues, and more research is needed to understand how they are activated.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

Cats likely have a reactive skin condition, while dogs may have a more complex, possibly cancerous one.

TEC kinases may help cause inflammation in vitiligo and could be targeted for treatment.

IL-19 and IL-24 help cells respond to DNA damage and could be targeted for cancer and age-related disease treatments.

Immunotherapy can help treat severe alopecia areata.

CD8 T cells need interferon gamma to cause Alopecia Areata.

Mast cell and nerve fiber interactions in mouse skin change with the hair cycle.

Microneedles offer a promising, painless, and efficient way to deliver vaccines and therapies directly to the skin.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

Blocking CD44 can reduce leukocyte migration in autoimmune skin diseases.

Some patients on immune therapy for melanoma may develop scarring hair loss, but cancer treatment remains effective.

Immune therapy for cancer can cause hair loss scars in some patients.

CD8+ virtual memory T cells may cause hair loss in alopecia areata.

UVB exposure in human skin causes macrophages to produce more IL-10 and less IL-12, leading to immunosuppression.